Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 17/20 | 0.48 |
| ▸ | AKT2 | P31751 | 10/20 | 0.47 |
| ▸ | AKT3 | Q9Y243 | 7/20 | 0.47 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | JAK1 | P23458 | 1/20 | 0.39 |
| ▸ | TYK2 | P29597 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31455682 | 0.92 | AKT1 (0.46) | AKT1AKT2AKT3DEGS1JAK2 | |
| SCHEMBL31455860 | 0.88 | AKT1 (0.47) | AKT1AKT2AKT3DEGS1 | |
| SCHEMBL31455914 | 0.87 | AKT1 (0.48) | AKT1AKT2AKT3 | |
| SCHEMBL31455633 | 0.86 | AKT1 (0.46) | AKT1AKT2AKT3 | |
| SCHEMBL31454982 | 0.85 | AKT1 (0.45) | AKT1AKT2AKT3 | |
| SCHEMBL31455334 | 0.82 | AKT1 (0.44) | AKT1AKT2AKT3 | |
| SCHEMBL31455906 | 0.81 | AKT1 (0.43) | AKT1AKT2AKT3 | |
| SCHEMBL31455567 | 0.80 | AKT1 (0.44) | AKT1AKT2AKT3DEGS1 | |
| SCHEMBL31455657 | 0.80 | AKT1 (0.65) | AKT1AKT2AKT3 | |
| SCHEMBL31455131 | 0.78 | AKT1 (0.65) | AKT1AKT2AKT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059562-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |